Andrew Warren

Andrew Warren has a diverse work experience in the biotech and venture capital industries. Andrew is currently working at HI-Bio as the Senior Director of Biology. Prior to this role, they held the position of Director of Biology & Program Team Lead at the same company.

Before joining HI-Bio, Andrew worked at Third Rock Ventures, where they served as a Senior Associate and later as an Associate.

Earlier in their career, Andrew was a Founding Scientist & Product Development Lead at Glympse Bio. The company focuses on developing noninvasive diagnostic technologies using proprietary nanoparticles.

Andrew also has a strong academic background, having conducted research at the Massachusetts Institute of Technology (MIT). Andrew was a Postdoctoral Associate and a PhD candidate during their time at MIT, where they developed a modular detection platform for disease diagnostics. Their research primarily focused on developing low-cost and paper-based cancer diagnostics using protease activity detection. Andrew collaborated with the Walt research group at Tufts University to improve the technique for single-molecule detection in urine samples.

Overall, Andrew Warren's work experience showcases their expertise in biology, program management, venture capital, and academic research.

Andrew Warren began their education in 2007 at The Johns Hopkins University, where they pursued a Bachelor of Science degree in Biomedical Engineering and Applied Mathematics & Statistics. Andrew completed their undergraduate studies in 2011. Following this, Andrew Warren attended the Massachusetts Institute of Technology from 2011 to 2016, where they earned a Doctor of Philosophy (Ph.D.) in Medical Engineering and Medical Physics.